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INTRODUCTION 
 Stroke is an important cause of disability and second most common cause of 
death, worldwide. Developing countries account for two thirds of death due to 
stroke 
1, 2
. As per the recent reports, the incidence and thirty day fatality rate is 
more in India when compared to developed countries
3
. The final outcome of 
stroke patients has been improved with various strategies like early diagnosis, 
early prophylactic treatment, early recognition of complications and 
mobilization
4
. 
 
 Although the direct effect of brain damage is the main cause for immediate 
mortality after stroke, the early mortality that occur within the first month after an 
acute stroke is commonly due to preventable medical complications, that occur 
either early or late during the course of recovery from stroke.
5 
These 
complications can be infections, neurologic-like recurrent stroke or seizures, 
thromboembolism, psychological problems, pain, and bed sores. High incidence 
of complications, ranging from 40% to 95%, following stroke have been found in 
previous studies.
6,7,8,9
 There have been many limitations in the previous studies of 
complications of acute stroke. Individual complications have been concentrated in 
most published studies. Different diagnostic criteria were also used in these 
studies to classify the complications. 
 
 A multicenter study (CAST-1) was conducted to examine the frequency and 
the factors associated with complications in acute stroke, as well as complications 
that could influence the outcome.
10
 Identifying the complications will aid the 
development of preventive strategies aimed at improving outcome after stroke. 
 
 
 
  
 
 
 
 
 
 
  
 
 
 
 
 
 
REVIEW OF LITERATURE 
 
NEUROLOGICAL COMPLICATIONS 
 Although advances have been made over the past two decades in the 
diagnosis and management of acute stroke, there is still high mortality after stroke 
which makes it the common cause of death in the developed world, after ischemic 
heart disease 
11
. 23-50% of deaths in patients with ischemic stroke are caused by 
the post stroke complications
12
. These complications, even when not life 
threatening, can prolong hospital stay, rehabilitation, functionally poor outcome 
and increased cost of care
12 - 14
. Both neurological and medical complications are 
found to occur following ischemic stroke. Recurrent stroke, brain oedema, 
hemorrhagic transformations, seizures and delirium are the neurological 
complications.
12,15,16
 Though these complications occur earlier- 48 to 72 hours of 
stroke onset, they are less frequent than medical complications.
15
 Some previous 
studies have indicated that direct consequence of neurological complications like 
brain damage to cause death after stroke in the first few days.
17,18
 
 
 
 
 
 
Brain oedema 
  
 One of the major causes of death within the first week of stroke is brain 
oedema.
19
Energy depletion in cerebral ischemia leads to ionic imbalance and 
causes brain oedema. Ischemic stroke patients are found to have two types of 
oedema- vasogenic and cytotoxic oedema. Characteristic feature of cytotoxic 
oedema is expansion of intracellular compartment by translocation of water from 
interstitium, with intact blood brain barrier.
20
 Blood brain barrier is compromised 
at the late stage of stroke causing vasogenic oedema which is characterised by 
fluid movement into extra vascular phases from the vascular compartment. There 
is expansion of brain volume due to vasogenic oedema which causes an increase 
in intracranial pressure, brain herniations and other ischemic injuries.
21
 Since 
cytotoxic oedema doesn‟t respond to anti- oedema treatment, the differentiation 
between vasogenic and cytotoxic oedema is important both for diagnostic and 
therapeutic purposes. This is done with the help of MRI: Vasogenic oedema 
causes water retention in brain tissues which can be seen on fluid –attenuated 
inversion recovery images and conventional T2- weighted images. On the other 
hand, there is overall reduction in the diffusivity of water molecules in cytotoxic 
oedema and is seen as high signal intensity in diffusion weighted images. Age of 
the patients as well as the extent and location of the infracted area determines the 
extent of swelling. Malignant middle cerebral artery syndrome and fatal brain 
oedema tend to develop more in younger patients than their older counterpart.
22
 
Older people are protected from developing space- occupying brain swelling 
probably because of cerebral atrophy, as shown in animal studies where 
significantly less stroke- induced oedema is seen to develop in ageing mice than 
in young animals.
19
 
Hemispheric oedema 
 There is 10-20% risk of cerebral oedema in patients with ischemic stroke 
involving the anterior circulation.
23
 Patients who have major anterior circulation 
occlusion tend to develop cerebral oedema within 4 days after stroke. Patients 
with large cerebral infarctions along with brain oedema usually present in coma. 
Brain oedema with midline structure shift is compression of brain stem is an 
important cause of mortality.
24
 Complete infarction of MCA territory and 
herniation of brain within 20 hours of onset of symptoms leads to condition called 
malignant MCA infarction.
19
 This kind of infarction is among the most 
devastating and life threatening neurological complications of ischemic stroke. 
Malignant MCA infarction accounts for a mortality rate between 40% and 80%, 
whereas that due to acute MCA infarctions caused by brain oedema and cerebral 
herniation is between 7% and 23%. Development of malignant MCA infarction 
can be predicted with a high sensitivity (91%) and specificity (94%), using Ct 
perfusion imaging which shows large areas of hypo perfusion and enhanced CT 
showing large hypo attenuation.
25
 Other predictive imaging findings include 
severe perfusion deficits on perfusion-weighted MRI within 6 hours or single 
PET scan, large diffusion- weighted imaging lesion volume and the decrease in 
diffusion coefficient in large area within 6 hours of stroke.  
Management 
 Elevation of the head end to 20-30 degree angle is used in the initial 
management of increased intracranial pressure, after an acute ischemic stroke, as 
it improves the venous drainage. Some of the other factors like hypoxia, 
hyperthermia, hpercapnia, hyperglycaemia and antihypertensive drugs, which can 
increase intracranial pressure, are to be avoided. Hemicraniectomy is 
recommended in selected patients who have substantial brain ischemic swellings 
and brain shifts that are life threatening.
26
 The principle behind removing the part 
of cranium is to prevent secondary damage to brain tissue and improves collateral 
perfusion by creating enough space for the expanding brain. 
Haemorrhagic transformation 
 A potentially serious and common complication of acute ischemic stroke is 
haemorrhagic transformation of brain infarct which occurs in 30-40% of clinical 
cases. Disruptions of neurovascular homeostasis and micro vascular integrity are 
the major causes of haemorrhagic transformation. There is an increased frequency 
of haemorrhagic transformation in patients managed with mechanical 
embolectomy and intra-arterial fibrinolytics (7%), intravenous alteplase (6%) than 
in patients who are treated with supportive care alone (0.6%).
27
 The risk of 
serious haemorrhagic transformation is increased with the use of anti- thrombotic, 
especially anti coagulants, in addition to thrombolytic drugs, after ischemic 
stroke. The risk of clinically detectable haemorrhage is increased when aspirin is 
used early. There is more possibility of development of haemorrhagic 
transformation in elderly patients with stroke due to factors which include 
impaired clearance of alteplase, age associated micro angiopathy, and increased 
frequency of transformation in cardio embolic infarcts when compared to 
atherosclerotic infarct.
28
 
 NINDS system classifies haemorrhagic transformation into two types- intra 
cerebral haematoma and haemorrhagic cerebral infarction. Intra cerebral 
haematoma is defined as CT findings of a homogenous, hyper dense lesion with 
or without oedema or mass effect within the brain. CT findings of an acute 
infarction with an irregular border within the vascular territory and with variable 
hyper and hypo density define haemorrhagic cerebral infarction. Haemorrhagic 
transformation expands the brain oedema leading to apoptotic glial cell and 
neuronal cell death, increased intracranial pressures, disruption and displacement 
of brain structures with high rate of mortality.
29
  
 Clinical state of the patient, risk of subsequent arterial or venous 
thromboembolism and the risk of recurrent intracerebral haemorrhage determines 
whether or when to restart anti thrombotic therapy after haemorrhagic 
transformation. Antiplatelet drugs might be a safer choice when compared to 
warfarin for patients with a high risk of re-bleeding but relatively lower risk for 
cerebral infarction; conversely, patients with a very high risk of 
thromboembolism can be restarted with warfarin after 7-10 days of onset of 
intracerebral haemorrhage.
30
 
 
Seizures and epilepsy 
 Seizures after ischemic stroke can either occur soon or can be delayed. Early 
seizures are defined as those which occur within 1 or 2 weeks of stroke and late 
seizures are those which occur thereafter. The frequency ranges from 2% to 23% 
for early seizures and between 3% and 67% for late seizures, depending on the 
study design, sample size and length of follow-up. Epilepsy (recurrent seizure) is 
seen to develop in only 2.5% to 4% of patients. 
 Cellular biochemical dysfunction causing electrically excitable tissue results 
in early seizure after stroke whereas development of meningocerebral gliosis and 
cicatrices are thought to result in late seizures. Several risk factors which have 
been identified includes stroke severity, multiple site involvement, embolic 
stroke, large cortical infarcts, size of the infarct, decreased consciousness and 
metabolic and hemodynamic disturbances.
31, 32 
 Seizures are found to occur more often in patients with cranial sinus 
thrombosis compared to those with arterial stroke. It may be the initial clinical 
presentation in central venous sinus thrombosis. 
 In some cases clinically undetectable non-convulsive seizures might account 
for deteriorating function. Recurrence rate is 50% in patients with late onset 
seizures whereas it is only 16% with early onset seizures. Frequency of recurrent 
seizures is related to the infarct and associated neuronal death. With the 
recurrence of late onset seizures, there is promotion of vascular cognitive 
impairment and the disability of patients with stroke is increased. In one study 
with 1220 patients, the in- hospital mortality rate in patients without seizure was 
only 14.4% compared to 37.9% in patients with early seizures. Conversely in two 
other studies, early seizures were associated with better outcome with regard to 
Scandinavian stroke scale scores. 
 It is a common practice to start short-term antiepileptic drug treatment for 3-6 
months to treat recurrent early seizures, whereas for late seizures long-term 
conventional therapy is needed. However, no study has assessed the advantages 
and disadvantages of short-term and long-term therapy. There is no need for long-
term antiepileptic to prevent of recurrence of early seizures. When compared to 
late onset seizures, in a retrospective study which particularly examined the risk 
factors for developing epilepsy.
35
 One study showed patients with first, late post-
stroke seizure was treated with  Gabapentin  monotherapy found to be 80% 
seizure remission after 30 months.
36
 Status epilepticus and early onset seizures are 
treated with intravenous benzodiazepines as the first choice drug, eventually 
followed by sodium valproate, phenytoin, gabapentin or lamotrigine are the  first-
line treatment for post-stroke seizures and epilepsy in younger patients who need 
anticoagulants or in elderly patients, and carbamazepine for patients who need no 
anticoagulation and with no bone health problems.
37
  
 There is no recommended usage for anti convulsants as prophylaxis in 
patients with any seizures following a recent stroke.
26
 
 
Recurrent stroke  
 The risk of recurrent stroke, after being high in the first week in patients with 
acute ischemic stroke, declines over time. Risk of recurrence is about 10%, 
between 2%-4% and about 5% at one week, one month and then yearly, 
respectively. The major risk factors for recurrent stroke include previous stroke, 
old age, hypertension, diabetes mellitus, cardiac diseases, atrial fibrillation, 
carotid stenosis, and smoking.
38
 Data from some studies indicate that patients 
with large artery atherosclerosis have the highest risk for stroke recurrence when 
compared to other etiological factors. Patients at risk of early recurrence stroke 
can be identified using transcranial Doppler which detects micro embolic signals. 
Prognostic score given by integration of clinical and imaging information score 
(recurrence risk estimator at 90 days [RRE- 90 score]) is used in the prediction of 
risk of early recurrence after ischemic stroke and could help to improve the 
clinical practice in acute stroke care.
39
  
 Each additional recurrence stroke increases the risk of early and late 
mortality, severe disability and dependency. Early clinical deterioration due to 
recurrent stroke was seen in 4.5% of 8291 patients with minor or transient 
ischemic stroke whereas it was 11.3% in 1964 patients who had a stroke.
40
 
 
Management 
 The need for early secondary prevention is substantiated by the early 
increased risk of recurrent stroke. Therefore, it is imperative to identify the cause 
and treat the stroke when possible. There is good evidence that early mobilisation 
and correction of abnormal physiological variables which will improve the 
clinical outcome and reduce the risk of recurrence of stroke.
26
 Multifactorial 
approach involving the blood sugar control, antiplatelet therapy, treatment of 
hypertension, reduction of elevated cholesterol, carotid endarterectomy, lifestyle 
changes and anticoagulation for atrial fibrillation might prevent at least 95% of 
recurrent strokes.
41
 Patients with ischemic stroke and symptomatic atherosclerotic 
narrowing of large intracranial or extracranial arteries have the options of surgical 
and endovascular interventions for treatment. 
 Delirium 
 
 Delirium is characterised by acute transient disturbance of consciousness and 
a change in cognition with fluctuating quality. The prevalence of delirium ranges 
from 13% to 48% among the patients with acute stroke. Some studies showed 
50% of the patients have delirium after one week after stroke. Though the cause 
of delirium in stroke is poorly understood, changes in the neurotransmitter 
concentration (serotonin, norepinephrine, acetylcholine, GABA and dopamine), 
hypothalamic- pituitary- adrenal axis activation, non-specific reaction to stress 
might have a role.
42
 Post-stroke delirium may be due to hypoperfusion in the 
frontal, pontine and parietal regions as indicated by single photon emission CT 
scans. Also in another study, there was an association between delirium and 
hypercortisolism in acute stroke. Risk factors for the development of post stroke 
delirium are pre-existing cognitive impairment, in previous stroke, poor pre-
stroke vision, old age, acute confusional states, apnoea, sleep apnoea, earlier 
treatment with anti-cholinergic drugs, left- sided brain lesions, total anterior 
circulation infarction, lesions in the caudate nucleus and thalamus, dysphagia on 
admission, intracerebral haemorrhages, cardioembolic stroke, neglect, infectious 
and metabolic disorders have all been identified. Post stroke delirium increases 
the risk of dementia, increases admission to an institution and prolongs hospital 
stay.
43 
    
Management 
 Treatment of post stroke delirium is usually the same as delirium in patients 
with other diseases.  
 
 
Central post- stroke pain 
  
 It occurs after subcortical, capsular, ventroposterolateral thalamic infarcts and 
lower brain stem infarcts, lateral medullary infarcts and anterior spinal artery 
infarcts. It is also known as dejerine roussy syndrome or thalamic pain syndrome. 
The infarcts in patients with central post-stroke pain are characterized by 
involvement of the spinothalamic tract with sparing of the lemniscal pathways, as 
evidenced by normal somatosensory evoked potentials.
44
 The prevalence of 
central post-stroke pain ranges between 1%-12% in all patients with stroke and 
18% of patients with a somatosensory disturbance. The onset of the symptoms to 
develop may take from days to years, but usually occur after several months. It 
will interfere with sleep and rehabilitation. Amitriptlyline and lamotrigine are the 
first line drugs and the second line drugs are gabapentin, fluvoxamine and 
mexiletine. Propofol and lidocaine can be given for short term pain relief. 
 
Headache 
 Acute ischemic stroke is usually accompanied by headache, occurring before 
(43%-60%; sentinel headache), concurrently (25%-30%; onset headache), or after 
(14%-27%; late- onset headache) focal neurological deficit. Headache following 
acute stroke normally begins on the first day. It is usually severe and continuous 
in nature and is of pressure type, lasts for 3-8 days. In the aftermath of major 
strokes, headaches are very common. Patient with anterior circulation have lesser 
chance of headache than patients with vertebrobasilar ischemia, because vessels 
are more densely innervated by nociceptive afferents in the posterior circulation 
than are those in the anterior circulation.
45
 In one study with onset headache, early 
neurological deterioration could be strongly predicted (98% of positive predictive 
value, 56% sensitivity and 99% of specificity).
46
 Secondary stroke prevention 
treatment drugs like dipyridamole can cause headache. Delayed headache are 
caused by factors like haemorrhagic transformation, oedema, intracranial 
hypertension, delayed interruption to the function of trigemino vascular system 
and delayed effects of ischemia and thrombosis by-products.  
 Post stroke headache respond to analgesic like paracetamol or might recover 
spontaneously. Opioid drugs have side effects like respiratory depression and 
hypotension and also alter the clinical picture and hence should be avoided. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
MEDICAL COMPLICATIONS 
 
Deep vein thrombosis and pulmonary embolism 
 One of the lethal and most feared complications in stroke patient is pulmonary 
embolism. Though it occurs in only 1% of stroke patients, pulmonary embolism 
accounts for 15% of deaths.
47
 Deep vein thrombosis of lower extremities is found 
in a great majority of patients who develop pulmonary embolism. Patients who 
are yet to walk tend to develop thrombi mostly in their paretic limb whereas some 
venous thrombi are found in the pelvic structures. The main causative factors that 
promote venous thrombosis and thromboembolism are an increase in acute phase 
reactants following brain ischemia which increases blood coagulability and stasis 
of blood.  
 
   Pulmonary embolism, a life- threatening complication for patients with stroke 
is preceded by a serious problem of deep vein thrombosis. After an acute stroke 
there is 2 to 10 percent prevalence of clinically evident DVT and even a higher 
prevalence of asymptomatic DVT.
48  
18 percent of patients with acute stroke were 
found to have proximal DVT at 21 days in a study which used magnetic  
resonance imaging (MRI),  and 28 to 80 percent patients were detected to have 
occult DVT in a study that employed fibrinogen scanning in patients with acute 
stroke and hemiplegia. 
49
 
 DVT may develop as early as the second day with a peak incidence between 
two and seven days.
50 
There is 15% risk of death in patients with stroke with an 
untreated proximal DVT.
50
There is a  predisposition to development of DVT in 
patients with hemiparesis and the degree of paresis is directly proportional to the 
risk of DVT. There may be 75 percent risk of DVT in the paretic side and on the 
nonparetic side it is 7 percent.
51 
High stroke severity, advanced age, atrial 
fibrillation and immobility are other additional risk factors for DVT. The 
noninvasive test of choice for patients with suspected DVT is compression 
ultrasonography.     
 Patients who happen to harbor deep vein thrombosis detected by venography 
and noninvasive techniques often have no abnormal symptoms or physical signs. 
Deep vein thrombosis is more likely to develop in patients with congestive heart 
failure and atrial fibrillation and those with severe leg weakness.
52
 In patients 
with hemiparesis the paretic limbs are most affected with venous occlusions. 
Since most of the pulmonary emboli are silent their true frequency is not known. 
 Use of subcutaneous LMWH or low- dose unfractionated heparin in order to 
prevent DVT and PE in patients with acute ischemic stroke with restricted 
mobility is recommended by most evidence-based clinical guidelines.
53
 Either 
subcutaneous heparin 5000U twice or thrice daily or LMWH like enoxaparin 
40mg daily can be used to prevent VTE in patients with acute ischemic stroke 
with restricted mobility. Patients with contraindications to anticoagulants are 
recommended intermittent pneumatic compression. 
   Patients with sudden chest pain, shortness of breath, change in respiratory 
pattern, hemoptysis, hypotension, hypoxemia, confusion, agitation are suspected 
to have pulmonary embolism. Evaluation should begin depending on the index of 
suspicion. Tests included are the following:  
1. Chest x-ray 
2. Electrocardiogram 
3. Arterial blood gas analysis 
4. Noninvasive studies of lower limb venous circulation 
5. Nuclear lung ventilation and perfusion scan 
6. Dye contrast angiography or pulmonary CT angiography 
Urgent treatment with intravenous full-dose heparin or LMWH is used in patients 
who are found to develop VTE or pulmonary embolism.  
 
Cardiac abnormalities 
 Mortality due to cardiac abnormalities is the second most common cause of 
death in patients with acute stroke, next only to neurological complications. 
Cardiac related death is highest during the first month after stroke and thereafter it 
declines in frequency.  
 Stroke patients even in whom there is no previous heart disease are found to 
have electrocardiogram changes consistent with ischemia, elevated troponin 
levels, creatine-phosphokinase-myoglobin levels and various cardiac arrhythmias. 
54  
Cardiac abnormalities are most likely due to lesions of particular regions of the 
brain. There are three ways by which stroke causes secondary cardiovascular, 
cardiac and respiratory changes. They are as follows,
55 
 
1.Critical structures such as the brainstem nuclei, hypothalamus and the cortex of 
the Insula of Reil that make up the central autonomic network, which activate 
autonomic descending fiber pathways to the lungs, heart and blood vessels are 
directly involved. 
2. Compression of the brainstem or hypothalamus, or both has a mass effect 
which activates the autonomic pathways 
3. Stress effects caused by acute brain lesion trigger the release of catecholamines 
and corticosteroids by stimulating the hypothalamic-pituitary axis. 
Cardiovascular effects like arrhythmias are seen in strokes that involve the insular 
cortex .Acute non-lacunar middle cerebral artery territory infarcts are the ones 
which commonly involve the insular cortex. Direct involvement of the medulla 
oblongata and brainstem compression can lead to vagal discharges, which can 
cause cardiac arrythmias, sinus bradycardia and even cardiac arrest, as well as a 
fall in diastolic blood pressure and elevation of systolic blood pressure changes 
found in patients with brain herniations and increased ICP usually called the 
Cushing response. 
 An increase in sympathetic tone is caused by stroke which elevates the levels 
of catecholamines that cause focal myocardial damage and subsequent 
arrhythmias. Patients with pre existent ischemic heart disease is especially more 
prone for myocardial infarction following a stroke. Coronary thrombosis is 
promoted by an increase in acute phase reactants that follows a stroke. The 
highest risk for cardiac arrhythmias is seen in older patients with cerebral 
hemispheric infarction.
56
 Patients with medullary and cerebral hemispheric 
infarcts commonly have heart rate variability. Patients with neurogenic cardiac 
arrhythmias can be treated both for arrhythmias and its cause using propranolol or 
other beta blockers.
56 
  
Swallowing Abnormalities 
 Dysphagia, defined by swallowing impairment of the upper digestive tract, is 
more specifically characterized as oropharyngeal dysphagia when related to 
stroke. The extended definition captures impairments in swallowing efficiency 
and safety that includes reduced range of movements, delay in the timing of 
movements and frank aspiration. 
57 
 Dysphagia which is a major risk factor for the 
development of aspiration pneumonia is very common after stroke. Systematic 
review of 24 studies which evaluated oropharyngeal dysphagia and aspiration in 
patients with stroke support the above mentioned observations.
57
  
The incidence of dysphagia after stroke was lowest, intermediate and highest  
when identified by screening methods like water swallow (37 to 45 percent), 
trained swallowing (51to 55 percent) ,and instrumental testing, mainly video 
fluoroscopy (64 to 78 percent), respectively.
57
 The dysphagia rates identified by 
instrumental testing may have been overestimated because the movement patterns 
due to the effect of aging were not distinguished from pathological dysphagia as 
per the definitions used in the studies. 
 On initial presentation, age more than 70, male gender, incomplete oral 
clearance, impaired pharyngeal response, disabling stroke and palatal asymmetry 
or weakness are the independent predictors of dysphagia. 
Screening bedside tests for swallowing dysfunction though are important they are 
not accurate enough. Overall sense of the presence of aspiration by the examiner 
and spontaneous cough during test swallows were found to be the best bedside 
predictors of aspiration to thin liquid in one study.
58   
When a formal screening 
protocol for dysphagia like water swallow test was used in a prospective, 
multicentre study, for all stroke patients, it was found to be associated with a 
significantly decreased risk of aspiration pneumonia when compared with no 
formal screen.
59
  
 Approximately one fourth to one third of patients with stroke is found to have 
symptomatic dysphagia. Patients who have had strokes that involve the brainstem 
or  bilateral hemispheric strokes are more commonly seen to have dysphagia and 
aspiration.
60
  It is also common in patients with severe strokes and in those with 
reduced consciousness and dementia. 
 Predictors of increased risk of aspiration are dysarthria, dysphonia, voice 
change after swallowing and abnormal cough to extricate food from the 
oropharynx.  A potential risk for aspiration can also be detected by a change in 
pulse oximetry following swallowing.
61
 Abnormalities of swallowing can be 
detected in approximately 50% of stroke patients using video fluoroscopic 
studies. 
 Choice of foods, instructions to the patients, physical therapy with guidance 
in positioning of food within the oral cavity and pharynx and the use of thermal 
stimulation can help prevent aspiration. Although there is temporary need for 
feeding tubes most of the patients resume feeding within months.  
 
Pulmonary Complications 
    One of the most common complications occurring  in about 5 percent of acute 
stroke  patients is pneumonia.
6
  In patients admitted to a neurologic intensive care 
unit with acute ischemic stroke and in who require nasogastric tube feeding there 
appears to be a higher incidence of stroke-related pneumonia(21 and 44 percent, 
respectively).
62 
 Pneumonia is the most common medical complication within four weeks of a 
supratentorial ischemic infarction and the most common cause of fever in the first 
48 hours of an acute stroke.
6 
Also most of the hospital readmission in stroke 
survivors in the first five years following an ischemic stroke are due to respiratory 
illness and pneumonia, as suggested by a retrospective data. An abnormal  water 
swallow test, age more than 65 years, cognitive impairment, severe poststroke 
disability and dysarthria or dysphasia are independent risk factors for pneumonia, 
in a prospective study of 412 patients with acute stroke.
63 
 Decreased level of 
consciousness and facial palsy were independent risk factors for pneumonia , in 
patients who needed nasogastric feeding. About 60 percent of post-stroke 
pneumonia is caused by aspiration.
6
 Abnormal entry of fluid, endogenous 
secretions or exogenous particulate substances into the lower airways and its 
pulmonary consequences is known as Aspiration pneumonia. Aspiration of 
microorganisms from the nasopharynx or oral cavity is the common cause for 
most pneumonia. 
 After stroke, pneumonia is common in the immediate and late periods. 
Pneumonia was a complication in 33% of patients dying with cerebrovascular 
disease, in a retrospective post-mortem study.
64  
 Poor mobilisation of secretions 
and atelectasis often occur in a recumbent position. Aspiration may be caused by 
difficulty in swallowing. There may be no or only poorly performed coughing and 
deep breathing. Also there are decreased chest movements on the hemiplegic side. 
Pneumonia and other infections, both in the hospital and afterwards, can also 
develop due to an immuno depressed state created by the stroke.
65 
Patients should 
be tested for swallowing function before oral feeding. Pneumonia after stroke can 
probably be prevented by physiotherapy or nursing technique.  
 
Metabolic and Nutritional Disorders 
 An important but seldom recognized complication of stroke, especially in 
elderly patients whose nutritional intake was poor even before their stroke, is 
prolonged under nutrition. It also serves as a predictor of poor outcome. Good 
gains in neurological functional status  was seen when the serum albumin levels 
were high.
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 Abnormal bone metabolism, gastrointestinal and cardiac dysfunction 
and diminished immune functions can result from malnutrition. Malnutrition also 
contributes to the formation and repair of decubitus ulcers. 
Gastric feeding tubes may be required when there is prolonged inability to 
swallow. Percutaneous endoscopic gastrostomy (PEG) tubes have helped many 
stroke patients maintain nutritional balance in spite of dysphagia. The outcome in 
stroke patients can improve with early PEG placement. Nutritional, electrolyte 
and fluid abnormalities can also occur during the acute stroke and recovery 
periods. Hyponatremia develops in approximately 15% of acute stroke patients. 
Inappropriate secretion of antidiuretic hormone (ADH) is responsible for post 
stroke hyponatremia as posited by Joynt et al.
67
  
 Some of the potential mechanisms, like increased release of ADH, damage to 
a widespread vasopressin neuronal system, resetting of osmoreceptors, effects on 
ADH secretion related to recumbency, damage to the anterior hypothalamus, and 
secondary stroke- related elevations in serum catecholamines and cortisol were 
reviewed by Joynt et al.
67
 Abnormalities of serum sodium concentrations have 
been posited to be caused by changes in the levels of atrial natriuretic factor. 
Volume depletion and overload must be excluded as contributing factors in 
hyponatremic patients. 
 
Urinary Tract Infections and Urinary Incontinence 
 One another common complication of stroke is urinary tract infections. Out of 
1455 patients, 17.2% developed urinary infections in an international trial of a 
neuroprotectant.
68  
The following two factors are probably the cause for a high 
frequency of urinary tract infections. The first is the placement of an indwelling 
catheter to empty the urinary bladder. This serves as a source for introduction and 
growth of bacteria. Hence continuous bladder drainage with indwelling catheter 
should be avoided. Using strict sterile techniques, intermittent catheterization is 
preferable. Condom catheters suffice in some men.  Second, stroke can alter the 
functioning of the external sphincter and urinary bladder. Urinary symptoms like 
frequency, urgency and retention are common even with uninfected bladders. 
Obstructive uropathy due to large prostrate is seen in men in the stroke age group 
who are often geriatric. 
 
Gastrointestinal Bleeding 
 Some patients with stroke and other brain diseases developing gastrointestinal 
haemorrhage has long been realized by physicians. This problem is usually called 
stress ulcers, Cushing’s ulcers, or hemorrhagic gastritis and when severe, can be 
life threatening. At a hospital in Edinburg, 18 of 607 (3%) patients with stroke 
developed gastrointestinal hemorrhages, as reported by Davenport and 
colleagues. One half of the hemorrhages were severe.
69 
 Most patients had melena 
or hematemesis, but one patient suddenly developed abdominal pain and went 
into hemodynamic shock.
69
 Gastrointestinal bleeding most commonly develops in 
older patients with decreased levels of consciousness and severe stroke. Risk of 
stress ulcers is also increased by corticosteroids that are given for brain oedema. 
H2 antagonists are recommended for prophylactic use in patients with large 
strokes and reduced awareness. 
 
Pressure Decubitus Ulcers 
 Bedsore is an iatrogenic complication of stroke which is preventable and 
significantly hinders the rehabilitation process. Patients who are immobilized, do 
not sense the need to change position and whose ability to reposition themselves 
is restricted, are at risk of developing bedsores if they are not frequently 
repositioned.
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 The risk of developing skin breakdown also increases when there 
is incontinence.The patient should be turned frequently and the skin should be 
kept dry and clean.  Nutrition should be given adequately. Pressure on 
immobilized or anesthetic limbs should be avoided. Heels can be spared from 
ulcers with the use of padded heel boots. Development of sacral pressure sores 
can be retarded with the use of waterbeds, egg-crate mattress or soft cotton 
padding. 
 The entire skin surface should be periodically examined by the physicians and 
nursing personnel for any area of early breakdown. Susceptible areas like the 
sacrum, buttocks, elbows, heels, toes, wrists and occiput should be paid particular 
attention. Pressure should be totally avoided on that area where an ulcer develops, 
the wound should be dressed, special mattresses should be used and the skin 
debrided and grafted, if necessary. 
 
Contractures and Shoulder Pain 
 Limb immobility when usually maintained in fixed, flexed positions at the 
knees and elbows can lead to fixed contractures. Frozen shoulders, shoulder pain, 
and the so-called shoulder-hand syndrome can develop with decreased shoulder 
movement. Out of 300 patients, 22% developed significant shoulder pain within 4 
months following stroke, in the Lund Stroke Register.
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 The shoulder-hand 
syndrome was found to develop in 36 of 132 (27%) of patients with hemiplegic 
stroke, in one study.
112
 Characteristics of the shoulder-hand syndrome includes, 
edema of the distal hand joints; swelling and pain over the carpal bones; pain and 
tenderness when flexing, abducting and externally rotating the upper arm.The 
likelihood of developing swelling of the upper extremity and shoulder pain is 
increased with severe shoulder spasticity, weakness and subluxation of the 
shoulder.Prevention of this disabling and unpleasant complication of stroke needs 
the shoulder joint to have an early full range of movement.  
 Low-dose corticosteroids and NSAIDS like indomethacin may be used in 
patients with shoulder pain.  Another complication of hemiparesis is subluxation 
of shoulder. The weak arm should be well supported. 
 
Peripheral Nerve Injuries 
 The most commonly involved nerve is that of peroneal nerve whose 
compression causes a foot drop. Compression of the nerve at the elbow, 
especially in wheelchair-bound patients, causes ulnar palsy. Occasionally, 
patients with reduced consciousness compress their femoral nerve in relation to 
pressure on the groin region.  
 
Osteopenia and Osteoporosis 
  Significant reduction in bone mineral density was found to occur on the 
hemiplegic side when the bone mineral densities were studied after stroke. The 
multiple causes include poor nutrition with inadequate vitamin D stores; lack of 
sunlight exposure; immobilization-induced calcium resorption from bone; and 
osteoporosis before the stroke. In patients with severe hemiplegic and prolonged 
immobilization, the hemi osteoporosis is most severe. 
  Hip and other fractures tend to occur predominantly on the hemiplegic side 
due to reduced bone density.Patients who are at risk of this complication can be 
given vitamin D supplements and calcium prophylactically.Exposure to sunlight 
and early mobilization are also important. In one small study, Zoledronate when 
given, as a single intravenous infusion of 4 mg within 35 days after stroke, 
prevented hip osteopenia, in one small study.
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Depression 
 Patients with a history of depression prior to their stroke are prone to become 
depressed even after a stroke.  Both major and minor depressive symptoms have 
been found to increase in prevalence, from 23% and 20%, respectively, 
immediately after the stroke to 35% and 26% at 6 months.
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 Since stroke related 
organic behavioral changes like apathy, abulia, impersistence, aprosodia and 
anosognosia are hard to separate from functional psychogenic reactions, there is 
often difficulty in the diagnosis. Because of slowed responses or aphasia, an 
accurate history may not be available. It may be difficult to interpret vegetative 
and autonomic signs also. There is often coexistence of psychological and 
neurologic effects which augment each other. Depressive patients become sad due 
to loss of function and cannot perform up to their potential. Left- hemispheric 
stroke was associated more with depression than right-hemisphere strokes.  
Higher frequency of depression are correlated to the more anteriorly placed 
infarcts, in the left hemisphere.
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 Constipation  
 Constipation is frequent in patients admitted with acute stroke. Several 
explanations for this may include: the patients are dehydrated, elderly, immobile 
and often treated with a number of drugs. Constipation is often caused by 
immobility and bed rest, which may in addition induce deconditioning, resulting 
in inadequate force to defecate. Hypovolemia is a frequent problem, both before 
and after stroke, the latter due to impaired thirst mechanisms, dysphagia and lack 
of attention to drinking possibilities. There is often an insufficient intake of 
dietary fibre by the hemiplegic population. The coordination between peristaltic 
wave and the relaxation of the pelvic floor and external sphincter is impaired 
when the sequencing of sympathetic and parasympathetic components of 
defecation is disrupted by lesions involving the pontine defecatory centre. 
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AIM OF THE STUDY 
  Study the frequency of complications after an acute ischemic stroke and their 
impact on the outcome of patients. 
 
OBJECTIVE 
 Whether any of the complications have an influence over the final outcome of 
the patient. 
 
INCLUSION CRITERIA 
 First ever stroke 
 Ischemic stroke 
 
EXCLUSION CRITERIA 
 Patients who have hemorrhagic stroke 
 Previous history of stroke. 
 Patients with traumatic brain injury. 
 
 
 
 
 
  
 
 
PLACE : Rajiv Gandhi Govt General Hospital 
  Chennai - 600003 
STUDY DESIGN : Prospective study 
STUDY PERIOD : December 2012 to December 2013 
ETHICAL CLEARANCE : Obtained 
CONSENT : Informed consent from all patients 
 
 
 
  
 
 
MATERIALS & METHODS 
 
 100 Patients with first ever stroke who were admitted in Rajiv Gandhi 
Government General Hospital were recruited in the study. Informed written 
consent was obtained from the patients before their enrollment. This was a 
prospective study approved by the Institutional ethical committee. 
 Detailed history including age, sex, symptoms at the time of stroke and risk 
factors was collected. All patients  were clinically examined and subjected to 
investigation like complete  blood count, renal function test, serum electrolytes, 
lipid profile, serum protein,ECG,ECHO,CT brain, carotid and vertebral Doppler 
and MRI brain in selected patients. 
 Stroke was classified into anterior circulation stroke and posterior circulation 
stroke. Severity of was classified using the National Institutes for Health Stroke 
Scale (NIHSS) as mild to moderate (score ≤10) and moderately severe to severe 
(score ≥11). 
 Occurrence of complication was observed in all patients during their hospital 
stay. Complications were defined according to standard  criteria
 7
( table 1) and 
included infections (UTI,RTI),shoulder pain, thromboembolism (DVT and 
Pulmonary embolism),complications of immobility (pressure / bed 
sores),psychological( depression) ,gastrointestinal (constipation,UGI bleed) and 
neurological (seizure,haemorrhagic transformation, brain edema). 
 Complications, when present, were treated accordingly. Patients were 
observed during their hospital stay, at the time of discharge and after one month. 
Assessment of functional outcome was done using the modified Rankin Scale 
(mRS). Patients who were not able to attend the follow -up clinic were assessed 
through phone calls. Outcome was grouped as good (mRS score 0-2) or poor 
(mRS score 3-6). 
 
 
 
 
  
 
 
 
 
 
 
                                   Table  1-Definition of complications 
 
Infections 
UTI: Clinical symptoms of UTI or positive urine culture 
Chest infection: Auscultation of respiratory crackles and fever or radiographic 
evidence, or new purulent sputum 
Other infection: Any pyrexia illness lasting for24 Hours 
Pain 
Shoulder pain: Pain in the shoulder area requiring analgesia on 2 or more 
consecutive days 
Other pain: Any other source of pain requiring regular Analgesia 
Thromboembolism 
DVT: Clinical diagnosis of DVT 
Pulmonary embolism: Clinical diagnosis of pulmonary Embolism 
Complications of immobility 
Falls: Any documented falls regardless of cause; fall with serious injury defined as 
one resulting in fracture, radiologic investigation, neurologic investigation, or 
wound suturing 
Pressure sore/skin break: Any skin break or necrosis resulting from either pressure 
or trivial trauma (skin trauma directly resulting from falls included) 
 
Psychological 
Depression: Low mood considered to interfere with daily activities or require 
pharmacologic or psychiatric intervention 
Emotionalism: Episodes of crying or laughing that are sudden or unheralded and 
not under social control 
Anxiety: Symptoms of anxiety considered to interfere with daily activities or 
requiring pharmacologic or psychiatric intervention 
Confusion: Cognitive disturbance considered to interfere with nursing care or 
rehabilitation 
Neurologic 
Recurrent stroke: Clinical features lasting more than 24 hours consistent with the 
World Health Organizations definition of stroke. The new event is unequivocally in 
a different arterial territory from an earlier one during the hospital stay. 
Epileptic seizure: Clinical diagnosis of focal and/or generalized seizure in a 
previously nonepileptic patient 
Unexplained events 
Miscellaneous: Any documented complication resulting in a specific medical or 
surgical intervention (eg, gastrointestinal hemorrhage, constipation, episodes of 
cardiac failure, cardiac arrhythmias, arthritis) 
RESULTS AND ANALYSIS 
 
 This study commenced with 100 patients of acute ischemic stroke who were 
followed up for 1 month from the onset of stroke. Various complications during 
their hospital stay were noted and treated accordingly. Outcomes of these patients 
were assessed using mRS score. 
 
 Descriptive statistics were utilized and all results are presented in terms of 
percentages. Categorical data were compared using chi square test or fischer‟s 
exact test, if appropriate. Statistical significance was p<0.05. 
 
 
 
 
 
 
 
  
 
 
 
SEX DISTRIBUTION 
 
Sex Frequency 
Male 68 
Female 32 
Total 100 
Table 2 
 A total of 100 patients were enrolled in the study, out of which 68 were male 
and 32 were female. 
 
 
 Figure 1 
 
 
 
SEX DISTRIBUTION 
 
 
Sex Without 
Complications 
With 
Complications 
Male 36 32 
68%
32%
Gender distribution 
Male
Female
Female 15 17 
Total 51 49 
Table 3 
 Among the 100 cases, 49 of them had at least one complication, out of which 
32 were male and 17 were female. The rest had no complications (36 male and 15 
female). 
 
 
Figure 2 
AGE DISTRIBUTION 
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 Age Without 
Complications 
With 
Complications 
Total 
<50 yrs 20 24 44 
>50 yrs 31 25 56 
Table 4 
 
 The patients were divided into two age groups, less than 50 years and more 
than 50 years, with 44 and 56 patients in each group respectively. However there 
was no statistically significant association with regard to the age group and 
complications. 
 Figure 3 
AGE DISTRIBUTION 
 
 
Age in years Male Female Total 
20 – 30 5 2 7 
31 – 40 11 2 13 
41 – 50 14 9 23 
51 – 60 24 6 30 
0
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35
<50 yrs >50 yrs
Age Group Distribution
Without Complication 
With Complication
61 – 70 11 10 21 
71 - 85 3 3 6 
Table 5 
 
 The age distribution of all the cases is shown in the above table. It ranges 
from 20 to 85 years. The mean age of the patients was 51.84±14 years. 
Distribution of the patients in the age group of 51-60 years was relatively higher 
than the other groups. 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 4 
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STROKE SYMPTOMS ASSOCIATED WITH COMPLICATIONS 
Symptoms Without 
Complications 
With 
Complications 
P Value 
<0.05 
Weakness 
Right 
Left 
 
21 (41.2%) 
22 (43.1%) 
 
22 (44.9%) 
21 (42.9%) 
 
0.864 
 
Dysphasia 
Absent 
Present 
 
44 (86.3%) 
7 (13.7%) 
 
34 (69.4%) 
15 (30.6%) 
 
0.042 
Dysarthria 
Absent 
Present 
 
30 (58.8%) 
21 (41.2%) 
 
19 (38.8%) 
30 (61.2%) 
 
0.045 
Dysphagia 
Absent 
Present 
 
49 (96.1%) 
2 (3.9%) 
 
35 (71.4%) 
14 (28.6%) 
 
0.001 
Loss of Sensation 
Absent 
Present 
 
40 (78.4%) 
11 (21.6%) 
 
43 (87.8%) 
6 (12.2%) 
 
0.215 
Unsteady gait 
Absent 
Present 
 
45 (88.2%) 
6 (11.8%) 
 
41 (83.7%) 
8 (16.3%) 
 
0.511 
Altered sensorium 
Absent 
Present 
 
50 (98%) 
1 (2%) 
 
46 (93.9%) 
3 (6.1%) 
 
0.288 
Vertigo 
Absent 
Present 
 
46 (90.2%) 
5 (9.8%) 
 
43 (87.8%) 
6 (12.2%) 
 
0.697 
Table 6 
 Various stroke symptoms were compared with complications and without 
complications. Statistically significant systems associated with complications 
were dysphagia (p-0.001), dysphasia (p-0.042), dysarthria (p-0.045), analyzed by 
chi square test. 
 
 
 
Figure 5 
RISK FACTORS 
 
0
10
20
30
40
50
Stroke Symptoms
Without Complications
With Complications
Risk factors Without 
Complications 
With 
Complications 
P value 
HTN 
 
Absent              
Present 
28 (54.9%) 
23 (45.1%) 
27 (55.1%) 
22 (44.9%) 
0.984 
DM 
 
Absent              
Present 
38 (74.5%) 
13 (25.5%) 
35 (71.4%) 
14 (28.6%) 
0.591 
AF 
 
Absent   
Present 
49 (96.1%) 
2 (3.9%) 
49 (100%) 
0 
0.161 
CAD 
 
Absent   
Present 
32 (62.7%) 
19 (37.3%) 
35 (71.4%) 
14 (28.6%) 
0.356 
TIA 
 
Absent   
Present 
43 (84.3%) 
8 (15.7%) 
38 (77.6%) 
11 (22.4%) 
0.389 
Smoking 
 
Absent      
Present 
27 (52.9%) 
24 (47.1%) 
23 (46.9%) 
26 (53.1%) 
0.548 
Alcohol Absent     
Present 
32 (62.7%) 
19 (37.3%) 
27 (55.1%) 
22 (44.9%) 
0.437 
Carotid  
Atherosclerosis 
Absent  
Present 
44 (86.3%) 
7 (13.7%) 
33 (67.3%) 
16 (32.7%) 
0.025 
Table 7 
 Above table shows the various risk factors for acute ischemic stroke. Among 
them carotid artery atherosclerosis was statistically significant with complications 
after stroke. (p- 0.025) 
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Lab Parameters Without 
Complications 
With 
Complications 
P value 
Hb 
 
Normal          
Abnormal 
18 (35.3%) 
33 (64.7%) 
25 (51%) 
24 (49%) 
0.112 
RBS 
 
<140 mg/dl        
>140 mg/dl 
42 (82.4%) 
9 (17.6%) 
32 (65.3%) 
17 (34.7%) 
0.052 
Urea 
 
<45mg/dl        
>45mg/dl 
50 (98%) 
1 (2%) 
44 (89.8%) 
5 (10.2%) 
0.083 
Creatinine 
 
<1.2 mg/dl               
>1.2 mg/dl 
40 (78.4%) 
11 (21.6%) 
36 (73.5%) 
13 (26.5%) 
0.561 
TGL 
 
<150            
>150 
35 (68.6%) 
16 (31.4%) 
36 (73.5%) 
13 (26.5%) 
0.594 
Total 
Protein 
 
Normal             
Abnormal 
42 (82.4%) 
9 (17.6%) 
42 (85.7%) 
7 (14.3%) 
0.647 
Albumin 
 
Normal     
Abnormal 
23 (45.1%) 
28 (54.9%) 
22 (44.9%) 
27 (55.1%) 
 
0.984 
Table 8 
  
 Various lab parameters were assessed in both the groups, with and without 
complications. Among them random blood sugar on admission was statistically 
significant in patients who had complications (p- 0.052). 
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STROKE CHARACTERISTICS 
 
Variables Without 
Complications 
With 
Complications 
P value 
ACS 40 (78.4%) 
 
40 (81.6%) 0.689 
PCS 11 (21.6%) 9 (18.4%) 0.689 
Hospital stays 
 
≤10 days 
>10 days 
25 (49%) 
26 (51%) 
2 (4.1%) 
47 (95.9%) 
0.000 
Stroke 
severity(NIHSS) 
 
Mild-
Moderate(0-
10) 
Moderately 
severe-
Severe(≥11) 
40 (78.4%) 
 
 
11 (21.6%) 
16 (32.7%) 
 
 
33 (67.3%) 
0.000 
Functional 
outcome 
 
Good(mRS-
0-2) 
Poor(mRS>2) 
23 (45.1%) 
 
28 (54.9%) 
6 (4.2%) 
 
43 (87.8%) 
0.000 
 Table 9 
 Among the 100 patients 80% had anterior circulation stroke and the rest 20% 
were found to have posterior circulation stroke.  
 
 The average length of hospital stay was 11.7 ± 5.08 days for patients who had 
no complications and 19.88 ± 6.6 days for those who developed complications. 47 
out of 49 (95.9%) patients who had complications were in the hospital for more 
than ten days, which is statistically significant (p- 0.000).  
All the patients were grouped using NIHSS score into mild to moderate (0-10) 
and moderately severe to severe (>11). Among the patients who had 
complications, 33 were in the moderately severe to severe group which is 
statistically significant (p- 0.000). 
 Functional outcome of these patients were assessed at the end of one month 
after stroke and grouped as good (≤2) and poor (>2) outcome according to mRS 
score. Out of 49 patients who had complications 43 (87.8%) had poor outcome 
which is statistically significant (p- 0.000) when compared to those who had no 
complications (54.9%). 
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COMPLICATIONS IN ACUTE ISCHEMIC STROKE 
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Stroke Characteristics Without Complications
With ComplicationsHospital Stay
NIHSS
Complications Percentage 
Respiratory tract infection 20 
Urinary tract infection 24 
Bed sore 23 
Dysphagia 28 
Constipation 40 
UGI bleed 1 
Seizure 1 
Haemorrhagic  transformation with 
oedema 
10 
Depression 22 
Shoulder pain 31 
Hematuria 4 
Hyponatremia 1 
Patients with at least one complication 49 
Table 10 
 Complications noted during the hospital stay are listed in the above table. Out 
of the 100 patients, 49 had at least one complication. The most commonly found 
complications in their order of frequency were constipation, shoulder pain, 
dysphagia, UTI, bed sore, depression and RTI. Neurological complications in the 
form of haemorrhagic transformation with brain oedema were found in 10 
patients and seizure in one patient. 
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DISCUSSION 
 The purpose of our study was to describe the occurrence of various 
complications in acute ischemic stroke patients and also assess the outcome of the 
patients using mRS score at admission, discharge and at the end of one month 
after stroke. 
 In our study 49% of the patients developed at least one complication during 
their hospital stay; however the frequency of complications reported in previous 
studies varies from 40% to 95%.
6,7,8,9 
 This wide variation may be due to the 
following reasons- no standard definitions for complications following the stroke, 
varied follow-up periods ranging from 1 week to 30 months, type and severity of 
stroke affecting the incidence and finally, some of the variations may be due to 
the demographic variables. 
 In our study the occurrence of complications in their order of frequency was 
constipation (41%), shoulder pain (31%), dysphagia (28%), UTI (24%), bed sore 
(23%), depression (22%), RTI (20%), haemorrhagic transformation with brain 
oedema (10%), hematuria (4%), UGI bleed (1%), seizure (1%) and hyponatremia 
(1%), with no incidence of thromboembolic complications. Only one patient was 
deceased at the end of one month follow-up. 
Constipation 
 In our study, 41% of the patients had constipation following an ischemic 
stroke which is unlike the study of Jose C Navarro et al who reported constipation 
in only 7.9% of his patients.
77
 
Shoulder pain 
 31% of the patients had shoulder pain in our study which is similar to the 
study by Braus DF et al 
72
 who found shoulder pain in 27% of his patients. 
Lindgren I et al 
71
 and Jeyaraj D Pandian et
 
 al
10
 showed the occurrence of 
shoulder pain to be around 22% and 7.8% respectively in their study. 
Dysphagia 
 Mann G et al 
78
 and Ramsey DJ et al
61
 had dysphagia in 51% and 50% of 
patients respectively whereas it was only 28% in our study. The incidence was 
increased to 64% in the study by Mann G et al when video fluoroscopy was used 
for the diagnosis of dysphagia. 
Infection 
 Commonly found infections were that of the urinary tract (24%) and 
respiratory tract (20%) which is similar to Katarzyna Grabska et al
 79 
with 19.5% 
of RTI and 23.3% of UTI and Jeyaraj D Pandian et al with 21.2% of RTI. But the 
incidence of UTI was only 8.7% in their study. In contrast to our study, Jose C 
Navarro et al had a lesser incidence with 9.4% of RTI and 4.9% of UTI. 
Bed sore 
 23% of patients in our study developed bed sores which are comparatively 
more to that of Jeyaraj D pandian et al and Jose C Navarro et al with only 7.8% 
and 2.6% respectively. 
 
 
UGI bleed 
 Frequency of UGI bleed was 1% in our study which is comparable to that of 
Jose C Navarro with 1.6%. Study of Jeyaraj D Pandian showed 2.23% and that of 
Davenport RJ  
69 
showed 3% of UGI bleed. 
Seizure 
 1% of patients in our study reported to have seizures after stroke which is 
similar to that of Bogousslavsky J et al
80
 with less than 1% and Jose C Navarro et 
al with 1.3%. However Jeyaraj D Pandian et al found a higher incidence about 
3.8% in their study. 
Hematuria 
 Frequency of hematuria was found to be higher in our study (4%) when 
compared to 1.1% in the study of Jose C Navarro. 
Depression 
 Studies with similar frequency with that of ours (22%) were Astrom M et   al 
81
 (25%) and Jeyaraj D Pandian et al (18.1%). A lesser frequency (4%) was found 
in the study of Jose C Navarro et al. 
Haemorrhagic transformation with brain edema 
 Incidence of hemorrhagic transformation was 10% in our study which is 
similar to that found in Krieger DW et al
25
 (10%-20%) but it was much higher 
(30%- 40%) in Lyden PD et al.
82
 
 
 Hyponatremia 
 Study of Luisa Fofi et al
83 
showed an incidence of hyponatremia in 6.3% of 
survivors and 20.7% of the deceased following an acute ischemic stroke.  Similar 
findings of about 4% were found in our study.  Study of Sreeraj K et al showed 
hyponatremia in 31.1% of their patients
84
. Sajadieh A et al demonstrated that a 
poor outcome was three times more likely in patients with hyponatremia.
85
 
Lab parameters 
 Though the prevalence of anaemia (57%) was more in the study group, it did 
not influence the complications. Abnormal sugar values (more than 140 mg/dl) 
was found to influence the complication with a frequency of 26%. This is similar 
to the study of Wong AA et al where the frequency of abnormal blood sugar 
(more than 126 mg/dl) was up to 50%.
86 
 Other parameters like serum creatinine, triglycerides, total proteins and 
albumin did not have any influence over the complications. 
 Strength of our present study is that it is a prospective study design which can 
provide more accurate information than a retrospective study. This is one among 
the few studies with data on majority of complications confined to ischemic 
stroke from a particular group of population. However there are few limitations in 
our study like non assessment of severity of complications, time of occurrence of 
stroke. 
 
SUMMARY  
 The results of the present study showed that the incidence of complications in 
patients after an acute ischemic stroke to be 49%. 
 The length of hospital stay, blood sugar, carotid artery atherosclerosis, 
severity of stroke (NIHSS score), dysphagia  and dysarthria were the factors with 
significant association with complications.  
 The complications encountered were constipation (40%), shoulder pain 
(31%), dysphagia(28%), UTI (24%), bed sore (23%), depression (22%), 
respiratory tract infection (20%), haemorrhagic transformation with brain oedema 
(10%), hematuria (4%), hyponatremia (1%), UGI bleed(1%) and seizures (1%). 
 Patients with complications were more likely to have poor outcome (87.8%) 
compared to patients without complications (54.9%).  
 Only 1% of patients were found to be deceased during follow up at the end of 
one month. 
  
 
 
 
 
 
CONCLUSION 
  In our study, the rate of medical complications was high in patients with 
acute ischemic stroke and those patients were found to have a poor outcome. 
Hence early diagnosis and prompt treatment of these complications is needed, in 
order to improve the outcome and thereby the quality of life of patients after 
stroke. 
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ABBREVIATIONS 
 
HTN Hypertension 
 
DM Diabetes Mellitus 
 
AF Atrial Fibrillation 
 
CAD Coronary Artery Disease 
 
TIA Transient Ischemic Attacks 
 
Hb Haemoglobin 
 
RBS Random Blood Sugar 
 
TGL Triglyceride 
 
TCH Total Cholesterol 
 
ACS Anterior Circulation Stroke 
 
PCS Posterior Circulation Stroke 
 
UGI Bleed Upper Gastro Intestinal Bleed 
 
RTI Respiratory Tract Infection 
 
UTI Urinary Tract Infection 
 
DVT Deep Vein Thrombosis 
 
PE Pulmonary Embolism 
 
LMWH Low Molecular Weight Heparin 
 
VTE Venous Thrombo Embolism 
 
HgeTr Haemorrhagic Transformation 
 
PROFORMA 
 
NAME      AGE  SEX                       
CLINIC NO:      ADM NO:                      WARD 
DOA                                                    DOD 
ADDRESS: 
PHONE NO:1.                                                                        2. 
LITERACY: 
OCCUPATION : INCOME: 
SOCIO ECONOMIC STATUS: 
Admission from 1.community 2.other hospital 3.emergency ward 
CLINICAL HISTORY: 
RISK FACTORS 
H/O Hypertension -         Yrs          on admission BP     
H/O Diabetes mellitus-       yrs 
H/O valvular heart disease                      prosthetic/ rheumatic 
H/O arrhythmia-   AF 
H/O MI /IHD 
Heart failure 
Past H/O stroke                                           Family history H/O stroke 
TIA                                                              PAD 
Tobacco     cigarette      beedi              yrs 
Alcohol                                                    ocp                                              drug abuse 
 
GENERAL PHYSICAL EXAMINATION                         
PR: 
BP: SBP                       DBP 
RR:                                 TEMP: 
 
SYSTEMIC EXAMINATION: 
CVS: 
RS: 
ABDOMINAL EXAMINATION: 
CNS: 
 
NIHSS Score: 
Modified Rankin Scale Score: Admission:    At Discharge: 1month 
POST STROKE COMPLICATION 
1.INFECTION-                                               symptoms                                               
 Respiratory                                                                               
Urinary tract 
Bedsore                                                            site                                                       grade 
2.GIT COMPLICATION 
Dysphagia 
UGI BLEED 
3.DVT           RT/LT 
4.DEPRESSION 
5.NEUROLOGIC –                           Recurrent stroke/Seizure 
6.OTHERS 
 
 
 
 
 
 
 
INVESTIGATION 
      
Na    
K    
LDL    
T.CH    
TGL    
HDL    
BILIRU    
OT    
PT    
SLP    
T.PROT    
A/G    
 URINE R/E 
 URINE C/S 
  SPUTUM C/S 
  PUS C/S 
SWAB C/S 
CXR 
 ECG 
 ECHO 
CT BRAIN         MCA           LT                     RT 
                             PCA 
                             ACA      
MRI BRAIN 
Carotid & vertebral Doppler 
TEMP CHART   D1             D2              D3            D4         D5        D6             D7            D8            
 
ANTIBIOTICS 
  
    
Hb    
 TLC    
DC-P    
L    
M    
E    
ESR    
PLAT    
PCV    
    
FBS    
PPBS    
RBS    
      
UREA    
CREAT    

 

 KEY TO MASTER CHART 
 
0    - Absent 
1    - Present 
ACS 1   - Anterior Circulation Stroke 
PCS 1   - Posterior Circulation Stroke 
 
OUTCOME 
0    - Good Outcome 
1    - Poor Outcome 
 
 
 
 
 
 
  
 
 
  
 
